Our latest news

Is powder segregation driving you nuts?

New Appointments at Seda

Offering clarity to the scope of the term ‘complex medicines’

Seda named ‘One to Watch’ in Alantra’s annual ranking of the fastest growing private pharma companies in the UK

New Publication from Seda’s Joanna Denbigh and the University of Manchester on novel, high resolution, label-free imaging in live cells with applications in complex targeted drug delivery systems

New Publication from Seda’s Modelling Group

Claire Patterson as co-lead author in high impact complex targeted nanomedicine (dendrimer) publication

Seda’s Jake Dickinson Shortlisted as Bionow Promising Technologist of the Year 2020

CellCentric’s first-in-class p300/CBP inhibitor CCS1477 publishes in Cancer Discovery

Paul Dickinson Presents: Developing Clinically Relevant Dissolution Specifications in APS Virtual Webinar Series